LSL Pharma Group Inc. (TSXV:LSL)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec 31, 2023
Pharmaceutical Products and Natural Health Products	10.03K

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec 31, 2023
Canada	10.03K